Twinbeech Capital LP Day One Biopharmaceuticals, Inc. Transaction History
Twinbeech Capital LP
- $4.95 Billion
- Q1 2025
A detailed history of Twinbeech Capital LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Twinbeech Capital LP holds 12,998 shares of DAWN stock, worth $81,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,998Holding current value
$81,757% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$40.4 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$37.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$36.2 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$28.5 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$25.5 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $462M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...